D1 and D5 Receptor Agonists
| Cat. No. | Product Name / Activity |
|---|---|
| 1534 | A 68930 hydrochloride |
| Potent and selective D1-like agonist | |
| 1701 | A 77636 hydrochloride |
| Potent and selective D1-like agonist; orally active | |
| 2073 | (R)-(-)-Apomorphine hydrochloride |
| Dopamine agonist; non-subtype-selective | |
| 1249 | CY 208-243 |
| Selective D1-like agonist | |
| 0884 | Dihydrexidine hydrochloride |
| Selective D1-like agonist | |
| 3548 | Dopamine hydrochloride |
| Endogenous agonist at dopamine D1-5 receptors | |
| 1659 | Fenoldopam hydrochloride |
| Selective D1-like partial agonist | |
| 0922 | SKF 38393 hydrobromide |
| Selective D1-like agonist | |
| 1447 | SKF 81297 hydrobromide |
| D1 agonist | |
| 2075 | SKF 83822 hydrobromide |
| Selective D1-like agonist |
Dopamine Scientific Review
Our Dopamine receptors review gives an overview of the dopamine receptor subtypes, and the receptor agonists and antagonists used to study them.
Request copyRequest PDFAddiction Life Science Poster
Written by Prof David Nutt, this poster summarizes the brain circuits and neurotransmitter systems that are affected by the main classes of addictive drugs.
Request copyDownload PDFDepression Life Science Poster
Written by P. Skolnich et al
Our Depression poster highlights presynaptic and postsynaptic targets for the potential treatment of major depressive disorder.
Request copyDownload PDFParkinson's Life Science Poster
Written by Anthony H.V. Schapira
Our Parkinson's disease (PD) poster summarizes the neurobiology of the disease, and highlights current therapeutic treatments for symptomatic PD.
Request copyDownload PDF